Nordic Bioproducts Group Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 30

Employees

  • Latest Deal Type
  • Series B

  • Investors
  • 4

Nordic Bioproducts Group General Information

Description

Developer of intelligent biotechnologies designed to redesign cellulose into high-value bioproducts. The company's biotechnologies help industries to combat the effects of global warming with innovative bioproducts and bioproduction technologies that work with food, pharma, plastics, and textiles, and create a healthy, carbon-neutral, and sustainable future for the planet and profit for the businesses, enabling industries to create bioproducts with positive economic, environmental, and social impact.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Tietotie 2
  • 02150 Espoo
  • Finland
+358 050
Primary Industry
Other Materials
Other Industries
Other Commercial Products
Corporate Office
  • Tietotie 2
  • 02150 Espoo
  • Finland
+358 050

Nordic Bioproducts Group Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nordic Bioproducts Group Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B) 19-Jan-2026 Completed Generating Revenue
4. Early Stage VC 30-Mar-2023 Completed Generating Revenue
3. Early Stage VC (Series B) 01-Aug-2022 Completed Generating Revenue
2. Seed Round 29-Oct-2021 $1.45M $1.45M Completed Startup
1. University Spin-Out 01-Jan-2019 Completed Startup
To view Nordic Bioproducts Group’s complete valuation and funding history, request access »

Nordic Bioproducts Group Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
Series A 264 $964.14 $964.14 1x $964.14 2.34%
To view Nordic Bioproducts Group’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Nordic Bioproducts Group Patents

Nordic Bioproducts Group Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026003424-A1 Novel reactor system to produce microcrystalline cellulose Pending 28-Jun-2024
WO-2025242961-A1 Pressure control system, method and apparatus for controlling pressure Pending 20-May-2024
WO-2023144448-A1 Low viscosity emulsions prepared from microcrystalline cellulose Inactive 27-Jan-2022
CA-3154636-A1 Homogeneous fiber product based on bio-oil and / or water and method for their production Pending 16-Sep-2019
EP-4031614-A1 Homogeneous fiber product based on bio-oil and/or water and method for their production Inactive 16-Sep-2019 C08L1/04
To view Nordic Bioproducts Group’s complete patent history, request access »

Nordic Bioproducts Group Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nordic Bioproducts Group Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Oji Holdings Holding Company Minority
Taaleri Bioindustry Growth/Expansion Minority
CMPC Ventures Corporate Venture Capital Minority
Aalto University University
To view Nordic Bioproducts Group’s complete investors history, request access »

Nordic Bioproducts Group FAQs

  • When was Nordic Bioproducts Group founded?

    Nordic Bioproducts Group was founded in 2019.

  • Where is Nordic Bioproducts Group headquartered?

    Nordic Bioproducts Group is headquartered in Espoo, Finland.

  • What is the size of Nordic Bioproducts Group?

    Nordic Bioproducts Group has 30 total employees.

  • What industry is Nordic Bioproducts Group in?

    Nordic Bioproducts Group’s primary industry is Other Materials.

  • Is Nordic Bioproducts Group a private or public company?

    Nordic Bioproducts Group is a Private company.

  • What is Nordic Bioproducts Group’s current revenue?

    The current revenue for Nordic Bioproducts Group is .

  • How much funding has Nordic Bioproducts Group raised over time?

    Nordic Bioproducts Group has raised $38.7M.

  • Who are Nordic Bioproducts Group’s investors?

    Oji Holdings, Taaleri Bioindustry, CMPC Ventures, and Aalto University have invested in Nordic Bioproducts Group.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process